Browsing Category
Pharma Industry News
4730 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Will ST‑503 be the non‑opioid breakthrough in pain therapy? Sangamo gets Fast Track nod
Sangamo Therapeutics gains FDA Fast Track for ST-503, a gene therapy targeting chronic neuropathic pain. Find out what this means for non-opioid innovation.
SciSparc targets quantum-powered bio data analysis with NeuroThera majority acquisition move
Find out how SciSparc is moving into quantum-powered bio data analysis through NeuroThera’s majority acquisition plan and what it could mean for investors.
Can zilganersen become the first disease-modifying therapy for Alexander disease?
Ionis wins FDA breakthrough therapy status for zilganersen in Alexander disease. Find out what this means for rare neurology drug development.
 Why Aptar is buying Sommaplast and what it signals for Brazil’s booming pharma packaging sector
AptarGroup has acquired Brazil’s Sommaplast to expand its oral-dosing packaging business. Find out how this move strengthens its position in Latin America.
Will payers embrace premium weight loss? Inside the reimbursement risks of next-gen GLP-1s
As GLP‑1 weight‑loss drugs climb toward blockbuster status, insurers and payers face tough choices on coverage. Can premium weight‑loss therapies become mainstream?
Etalanetug shows over 90% tau biomarker reduction in Eisai’s DIAD trial update at CTAD 2025
Eisai’s etalanetug shows up to 90% reduction in novel tau biomarker in Alzheimer’s patients. Find out how it could reshape the AD treatment landscape.
Q32 Bio divests complement inhibitor ADX-097 as Akebia Therapeutics builds rare kidney disease pipeline
Discover how Q32 Bio’s ADX-097 sale to Akebia Therapeutics reshapes both companies’ pipelines, balance sheets, and investor outlook.
Kala Bio lands $6m lifeline as David E. Lazar takes control in turnaround bid
Find out how Kala Bio’s $6 million financing and leadership reset after the failed KPI-012 trial is shaping its survival strategy and investor outlook.
Apimeds–MindWave merger reshapes APUS into biotech and AI digital treasury hybrid backed by $100m PIPE
Apimeds and MindWave merge in a $100M PIPE-backed deal to create a biotech and AI digital treasury hybrid. Find out how APUS is reshaping its future today.
ATNM-400 from Actinium Pharmaceuticals (ATNM) shows breakthrough promise in resistant breast cancer
Actinium’s ATNM-400 shows potent activity in resistant breast cancer and TNBC. Find out what the new SABCS 2025 data reveal about this radiopharma candidate.